Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
586
-
Total 13F shares, excl. options
-
52,755,099
-
Shares change
-
+35,567
-
Total reported value, excl. options
-
$5,250,612,391
-
Value change
-
-$6,275,737
-
Put/Call ratio
-
138%
-
Number of buys
-
163
-
Number of sells
-
364
-
Price
-
$99.50
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2019
As of 30 Sep 2019 ISHARES TR - ISHARES BIOTECH (IBB) had 586 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,755,099 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, BARCLAYS PLC, GOLDMAN SACHS GROUP INC, UBS Group AG, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, NATIXIS, and ROYAL BANK OF CANADA.
This table shows 589 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.